Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ

Journal of Pathology

Volumn 198, Issue 4, 2002, Pages 458-467

  Boecker, Werner ^a   Moll, Roland ^b   Dervan, Peter ^c   Burger, Horst ^a   Poremba, Christopher ^a   Diallo, Raihanatou Ina ^a   Herbst, Hermann ^a   Schmidt, Ansgar ^b   Lerch Markus M , M M ^d   Buchwalow, Igor B ^d  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Breast; Ductal carcinoma in situ; Progenitor (stem) cells; Stem cell model

Indexed keywords

ALPHA ACTIN; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 8; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST DISEASE; BREAST DUCT; BREAST EPITHELIUM; BREAST HYPERPLASIA; CARCINOMA IN SITU; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; MALIGNANT TRANSFORMATION; MYOEPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; STEM CELL; THEORETICAL MODEL; TUMOR CLASSIFICATION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIFFERENTIATION; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; STEM CELLS; TUMOR STEM CELLS;

EID: 0036900448     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1241     Document Type: Article

References (36)

1. Purkis PE, Steel JB, Mackenzie IC, Nathrath WB, Leigh IM, Lane EB. Antibody markers of basal cells in complex epithelia. J Cell Sci 1990; 97(Pt 1): 39-50.
2. Taylor-Papadimitriou J, Wetzels RHW, Ramaekers FC. Intermediate filament protein expression in normal and malignant human mammary epithelial cells. In Genes, Oncogenes and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, Dickson RB, Lippmann ME (eds). Kluwer Academic Publishers: Boston, 1991; 355-378.
3. Boecker W, Moll R, Poremba C, et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 2002; 82(6): 737-746.
4. Bodian CA, Perzin KH, Lattes R, Hoffmann P. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications. Cancer 1993; 71: 3908-3913.
5. Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR. A prospective study of the development of breast cancer in 16 692 women with benign breast disease. Am J Epidemiol 1988; 128: 467-477.
6. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-151.
7. Lakhani SR, Chaggar R, Davies S, et al. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol 1999; 189: 496-503.
8. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer [published erratum appears in J Am Med Assoc 1992; 267: 1780]. J Am Med Assoc 1992; 267: 941-944. 1
9. Mommers EC, van Diest PJ, Leonhart AM, Meijer CJ, Baak JP. Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. Hum Pathol 1998; 29: 1539-1545.
10. Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridisation and high-molecular-weight cytokeratin expression patterns. J Pathol 2001; 195: 415-421.
11. Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 1996; 74: 129-135.
12. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998; 90: 697-703.
13. Shoker BS, Jarvis C, Clarke RB, et al. Abnormal regulation of the oestrogen receptor in benign breast lesions. J Clin Pathol 2000; 53: 778-783.
14. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
15. Elston CW, Ellis IO. The Breast (1st edn). Harcourt Brace: Edinburgh, 1998.
16. Holland R. Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167-180.
17. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast (1st edn). Churchill Livingstone: Edinburgh, 1987.
18. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154-1157.
19. Sloane JP. Biopsy Pathology of the Breast (2nd edn). Arnold: London, 2001.
20. Boecker W, Bier B, Freytag G, et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Virchows Arch A [Pathol Anat Histopathol] 1992; 421: 323-330.
21. Moinfar F, Man YG, Lininger RA, Bodian C, Tavassoli FA. Use of keratin 35βE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia, ductal type - benign and malignant intraductal proliferations. Am J Surg Pathol 1999; 23: 1048-1058.
22. Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000; 37: 232-240.
23. Raju U, Crissman JD, Zarbo RJ, Gottlieb C. Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast. Am J Surg Pathol 1990; 14: 939-947.
24. Achtstaetter T, Hatzfeld M, Quinlan RA, Parmelee DC Franke WW. Separation of cytokeratin polypeptides by gel electrophoretic and chromatographic techniques and their identification by immunoblotting. Methods Enzymol 1986; 134: 355-371.
25. Walker RA. Are all ductal proliferations of the breast premalignant? J Pathol 2001; 195: 401-403.
26. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997; 6: 297-230.
27. Buerger H, Mommers EC, Littmann R, et al. Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Am J Clin Pathol 2000; 114: 854-859.
28. Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999; 188: 237-244.
29. Tavassoli FA. Pathology of the Breast (2nd edn). Appleton and Lange: Norwalk, 2000.
30. Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 1996; 78: 258-266.
31. Buerger H, Otterbach F, Simon R, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402.
32. Buerger H, Otterbach F, Simon R, et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999; 189: 521-526.
33. Diallo R, Schaefer KL, Poremba C, et al. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J Pathol 2001; 193: 27-32.
34. Kasami M, Vnencak-Jones CL, Manning S, Dupont WD, Page DL. Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy. Am J Pathol 1997; 150: 1925-1932.
35. Radford DM, Fair KL, Phillips NJ, et al. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, l3q, l6q, 17p and l7q. Cancer Res 1995; 55: 3399-3405.
36. Ellis IO, Pinder SE, Lee AH, Elston CW. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going? Semin Diagn Pathol 1999; 16: 202-208.